Oxford and Prenetics commit to COVID diagnostics development in multi-million dollar deal

Oxford University and Prenetics Limited have signed a multi-million dollar collaboration to further develop rapid molecular testing technology for infectious diseases.

By |2021-04-23T10:21:39+01:00April 23, 2021|News|
Go to Top